Postoperative Catheterization After Anterior Colporrhaphy
Study Details
Study Description
Brief Summary
Randomised controled multicenter trial about the appropriate length of postoperative catheterization after anterior colporrhaphy. Patients are included at the moment that they are planned for surgery and are allocated to one of the study arms after the operation in the recovery by a digital randomisation-procedure. 230 patients will be enrolled in the study and half of the patients will have a catheter during five days postoperatively and the other half will be catheterized only during two days. Main outcome measurements regards replacement of a catheter because of bladder retention and the occurence of cystitis.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: 1 postoperative catheterization after anterior colporrhaphy during five days. |
Procedure: postoperative catheterization
postoperative catheterization after anterior colporrhaphy for five days versus two days.
Other Names:
|
Active Comparator: 2. postoperative catheterization after anterior colporrhaphy during two days |
Procedure: postoperative catheterization
postoperative catheterization after anterior colporrhaphy for five days versus two days.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- how many patients do need replacement of a catheter because of urine retention in both groups: 2 days versus 5 days in dwelling catheterization after anterior colporrhaphy [6-8 hours after removal of catheter]
Secondary Outcome Measures
- how many patients develop cystitis after catheterization in both groups: 2 days versus 5 days in dwelling catheterization after anterior colporrhaphy [6 weeks after surgery]
Eligibility Criteria
Criteria
Inclusion Criteria:
- all patients planned for a cystocele repair
Exclusion Criteria:
-
patients who already have voiding problems before the operation not related to the cystocele
-
patients that are not capable of understanding our patient information form because of mental status or language
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | atriumMC | Heerlen | Netherlands | 6401 CX | |
2 | Maastricht university medical center | Maastricht | Netherlands | 6229 HC |
Sponsors and Collaborators
- Atrium Medical Center
- Maastricht University
Investigators
- Study Director: Frans Roumen, Dr, Atrium Medical Center
- Principal Investigator: Mirjam Weemhoff, DRS, Maastricht University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 05-P-47